"RhoGEFs as signaling platforms of chemotactic GPCRs"

Add to your list(s) Download to your calendar using vCal

• José Vázquez-Prado; Department of Pharmacology, The Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV-IPN) Mexico
• Thursday 09 March 2017, 13:00-14:00
• Babraham - The Brian Heap Seminar Room.

If you have a question about this talk, please contact Bobbie Claxton.

Hosted By: Dr Heidi Welch

Cancer cells and stroma cells in tumors secrete chemotactic agonists that exacerbate invasive behavior, promote tumor-induced angiogenesis, and recruit protumoral bone marrow-derived cells. In response to shallow gradients of chemotactic stimuli recognized by G protein-coupled receptors (GPCRs), Gbg-dependent effectors such as Phosphoinositide-3-kinases and Rac guanine nucleotide exchange factors, such as P-Rex1, contribute to the activation of Rho GTPases and their cytoskeletal-remodeling effectors. P-Rex1, as many other Rho guanine nucleotide exchange factors coexpressed in protumoral cells, is a multidomain protein that interacts with multiple regulators and upstream signaling partners. The role of P-Rex1 as a signaling platform of chemotactic GPC Rs will be discussed based on its interactions with GPC Rs, Gbg and the serine/threonine kinases mTOR and PKA . Overall, the proven relevance of multiple chemokines in oncogenic settings has pointed to RhoGEFs as potential pharmacologic targets in cancer research.

This talk is part of the Babraham Seminar series.

This talk is included in these lists:

• Babraham - The Brian Heap Seminar Room
• Babraham Seminar
• Graduate-Seminars
• se393's list

Note that ex-directory lists are not shown.